Home・Aktien・Cumberland Pharmaceuticals Inc

C
Cumberland Pharmaceuticals Inc

Geschlossen

6.79 -11.24

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

6.79

Max

7.04

Schlüsselkennzahlen
By Trading Economics
Einkommen	-1.9M -3.3M
Verkäufe	-4.5M 9.1M
EPS	-0.22
Gewinnspanne	-35.998
Angestellte	93
EBITDA	-1.8M -1.8M

Dividenden
By Acuity
Nächstes Ergebnis	4. Aug. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	21M 89M
Vorheriger Eröffnungskurs	18.03
Vorheriger Schlusskurs	6.79

Cumberland Pharmaceuticals Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Juli 2026, 23:51 UTC

Bitcoin dips amid crypto volatility, while Ethereum rises; South Korea's GDP trends and geopolitical tensions raise concerns for regional market stability.

19. Juli 2026, 23:51 UTC

"Bitcoin dips as Ethereum rises amid geopolitical tensions and South Korea's GDP data, with key economic indicators on the horizon."

19. Juli 2026, 23:51 UTC

"Bitcoin Declines Amid Mixed Crypto Performance; South Korea's GDP and ASEAN Interest Rate Talks Signal Potential Market Shifts."

19. Juli 2026, 23:51 UTC

Mixed cryptocurrency performance amid geopolitical tensions and economic uncertainties, with South Korea's GDP figures and rising U.S. margin debt raising investor concerns.

19. Juli 2026, 23:51 UTC

Bitcoin is trading lower today, continuing a trend following Friday's declines in U.S. equity markets. It remains above its 20-day moving average.

19. Juli 2026, 23:41 UTC

Canada's New Housing Price Index set for July 24, with a forecasted decline of -0.2% amid cautious market sentiment and ongoing economic pressures.

19. Juli 2026, 23:21 UTC

Upcoming Chicago Fed National Activity Index release on July 23, 2026, may signal U.S. economic growth amidst mixed sentiment and inflation concerns.

19. Juli 2026, 23:21 UTC

Canada's Retail Sales Ex Autos Expected to Rise 0.4% in May Amid Cautious Optimism on Consumer Spending

19. Juli 2026, 23:11 UTC

Correlated Moves

During after-market hours, SGD/CHF is higher, reflecting a slight gain since Friday's close. The asset exhibited notable volatility amid broader macroeconomic trends.

19. Juli 2026, 23:11 UTC

ECB Expected to Maintain Interest Rate at 2.4% Amid Rising Energy Costs and Global Economic Concerns

19. Juli 2026, 23:11 UTC

Euro Area's Deposit Facility Rate Expected to Hold Steady at 0.0225% Amid Cautious Market Sentiment and Geopolitical Tensions

19. Juli 2026, 23:01 UTC

China's Loan Prime Rate Expected to Hold Steady at 3.50% Amid Cautious Economic Sentiment and Geopolitical Tensions Ahead of July Release

19. Juli 2026, 23:01 UTC

China's Loan Prime Rate (LPR) 1Y release on July 20, 2026, forecasted at a cautious 0.03%, amid economic concerns impacting consumer spending and credit demand.

19. Juli 2026, 23:01 UTC

After-market trading for GBP/ZAR shows gains since Friday's close, fluctuating throughout the session and remaining near the upper end of its one-month range.

19. Juli 2026, 23:01 UTC

Macro News

Correlated Moves

GBP/USD declines in after-hours trading as the U.S. dollar strengthens against major currencies, reflecting broader investor sentiment and geopolitical tensions.

19. Juli 2026, 23:01 UTC

GBP/CHF is higher in after-market trading, reaching the upper end of its one-month trading range despite no specific news identified for today's move.

19. Juli 2026, 22:51 UTC

USD/NOK is trading higher in after-market hours, moving from a low to a high since Friday's close, despite remaining below its 20-day moving average.

19. Juli 2026, 22:31 UTC

Japan's Inflation Rate Release on July 23, 2026: Market Eyes Potential Impact of Recent Economic Shifts and Extreme Weather on Monetary Policy.

19. Juli 2026, 22:31 UTC

Japan's Core Inflation Rate Expected to Rise to 1.6% Amid Economic Concerns and Geopolitical Tensions Ahead of July Release

19. Juli 2026, 22:21 UTC

GBP/NOK is higher in after-hours trading, reaching the upper end of its one-month range. No specific news was identified for this price move.

19. Juli 2026, 22:21 UTC

EUR/SEK advanced in after-market trading, reaching a peak above previous levels. The performance contrasts with its position in the one-month trading range.

19. Juli 2026, 22:21 UTC

Mortgage Rates Hit Nine-Month High at 6.65%, Raising Concerns Over Housing Affordability and Consumer Spending Ahead of Upcoming MBA Data Release

19. Juli 2026, 22:21 UTC

Canada's June 2026 Inflation Rate Release Sparks Caution Amid Rising Gas Prices and Mixed Market Expectations

19. Juli 2026, 22:21 UTC

Canada's Inflation Rate Expected to Decrease by 0.002% in June, Signaling Potential Deflationary Pressures Ahead of July Release

19. Juli 2026, 22:21 UTC

Canada's Core Inflation Rate Release on July 20, 2026 Expected to Impact Monetary Policy Amid Ongoing Economic Pressures.

19. Juli 2026, 22:21 UTC

Correlated Moves

Avalanche is declining during Sunday’s session, reflecting broader cryptocurrency market sentiment. The asset remains below its 20-day moving average.

19. Juli 2026, 22:11 UTC

Correlated Moves

Gold/CAD is declining in the ongoing session, continuing a downward trend since Friday's close, with Silver also showing weakness.

19. Juli 2026, 22:11 UTC

Correlated Moves

Gold Ounce vs Euro is trading lower, reflecting a decline since Friday's close, influenced by a drop in Silver prices and macroeconomic factors.

19. Juli 2026, 22:11 UTC

Correlated Moves

Gold/JPY is trading lower, continuing a decline since Friday's close. The asset remains below its 20-day moving average amid broader weakness in precious metals.

19. Juli 2026, 22:11 UTC

Macro News

Crude oil prices are rising amid concerns over shipping route disruptions and escalating U.S.-Iran tensions. Prices have regained momentum above the 20-day moving average.

Peer-Vergleich

Kursveränderung

Cumberland Pharmaceuticals Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für Cumberland Pharmaceuticals Inc – Dist abgegeben haben.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über Cumberland Pharmaceuticals Inc

Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products for hospital acute care, gastroenterology, and oncology in the United States and internationally. The company offers Acetadote, an injection for the treatment of acetaminophen poisoning; Caldolor, an injection for the treatment of pain and fever; Kristalose, a prescription laxative oral solution for the treatment of constipation; Omeclamox-Pak for the treatment of Helicobacter pylori infection and duodenal ulcer disease; Vaprisol, an injection for treating euvolemic and hypervolemic hyponatremia; Sancuso, an injection for the treatment of chemotherapy treatment; and Vibativ, an injection for the treatment of certain serious bacterial infections, including hospital-acquired and ventilator-associated bacterial pneumonia, as well as complicated skin and skin structure infections. It develops RediTrex injection for the treatment of active rheumatoid, juvenile idiopathic, and severe psoriatic arthritis, as well as disabling psoriasis. In addition, the company is developing ifetroban, a product candidate that is in phase II clinical trial for the treatment of aspirin-exacerbated respiratory disease, systemic sclerosis, and duchenne muscular dystrophy; and has completed phase II clinical trial for the treatment of hepatorenal syndrome and portal hypertension. Further, it develops a clinical program for the use of ifetroban to treat progressive fibrosing interstitial lung diseases. The company was incorporated in 1999 and is headquartered in Nashville, Tennessee.